Viatris (VTRS) Gross Margin (2020 - 2026)

Viatris' (VTRS) quarterly Gross Margin came in at 32.97% in Q1 2026, down 271.0% year-on-year from 19.28% in Q1 2025, and up 7.43% quarter-over-quarter from 30.69% in Q4 2025.

Viatris (VTRS) Gross Margin (2020 - 2026) Analysis & Trends

Viatris' Gross Margin history runs 7 years deep, the most recent figure standing at 32.97% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 271.0% year-over-year to 32.97% in Q1 2026; TTM through Mar 2026 was 34.36%, a 264.0% decrease from a year earlier, with the FY2025 full-year figure at 35.06%, down 321.0% from the prior year.
  • Gross Margin improved to 32.97% in Q1 2026 per VTRS's latest filing, from 30.69% in the prior quarter.
  • Across five years, Gross Margin topped out at 42.99% in Q3 2023 and bottomed at 30.69% in Q4 2025.
  • The 5-year median for Gross Margin is 38.9% (2024), against an average of 38.42%.
  • Across the five-year window, Gross Margin surged 1677 bps in 2022 and tumbled 713 bps in 2024, its largest moves.
  • Year by year, Gross Margin stood at 32.57% in 2022, then gained by 29 bps to 42.03% in 2023, then fell by 17 bps to 34.9% in 2024, then fell by 12 bps to 30.69% in 2025, then climbed by 7 bps to 32.97% in 2026.
  • Per Business Quant, the three latest VTRS Gross Margin figures stand at 32.97% (Q1 2026), 30.69% (Q4 2025), and 36.48% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 55.84%

Historic Data

Download Data
DateValue
Mar 31, 2026 32.97%
Dec 31, 2025 30.69%
Sep 30, 2025 36.48%
Jun 30, 2025 37.35%
Mar 31, 2025 35.68%
Dec 31, 2024 34.90%
Sep 30, 2024 38.90%
Jun 30, 2024 38.18%
Mar 31, 2024 41.05%
Dec 31, 2023 42.03%
Sep 30, 2023 42.99%
Jun 30, 2023 41.05%
Mar 31, 2023 41.36%
Dec 31, 2022 32.57%
Sep 30, 2022 42.99%
Jun 30, 2022 41.49%
Mar 31, 2022 42.39%
Dec 31, 2021 35.11%
Sep 30, 2021 34.82%
Jun 30, 2021 29.11%